The Michael J. Fox Foundation for Parkinson's Research Revenue and Competitors

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • The Michael J. Fox Foundation for Parkinson's Research's estimated annual revenue is currently $46.5M per year.(i)
  • The Michael J. Fox Foundation for Parkinson's Research's estimated revenue per employee is $129,540

Employee Data

  • The Michael J. Fox Foundation for Parkinson's Research has 359 Employees.(i)
  • The Michael J. Fox Foundation for Parkinson's Research grew their employee count by 10% last year.

The Michael J. Fox Foundation for Parkinson's Research's People

NameTitleEmail/Phone
1
Co-Founder and CEOReveal Email/Phone
2
Chief StaffReveal Email/Phone
3
SVP Brand MarketingReveal Email/Phone
4
SVP Public PolicyReveal Email/Phone
5
VP Marketing Data IntelligenceReveal Email/Phone
6
SVP FinanceReveal Email/Phone
7
VP, Community FundraisingReveal Email/Phone
8
Program Officer, Research OperationsReveal Email/Phone
9
Advancement OfficerReveal Email/Phone
10
VP, Leadership GivingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M15-6%N/AN/A
#2
$2.5M313%N/AN/A
#3
$6.2M683%N/AN/A
#4
$8.1M7914%N/AN/A
#5
$0.8M138%N/AN/A
#6
$0.9M15-6%N/AN/A
#7
$62.7M4925%N/AN/A
#8
$1.5M2111%N/AN/A
#9
$2770.9M19404N/AN/AN/A
#10
$10.4M102-6%N/AN/A
Add Company

What Is The Michael J. Fox Foundation for Parkinson's Research?

The Michael J. Fox Foundation for Parkinson's Research is dedicated to finding a cure for Parkinson's disease through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's today.

keywords:N/A

N/A

Total Funding

359

Number of Employees

$46.5M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

The Michael J. Fox Foundation for Parkinson's Research News

2022-04-17 - Neuropore Therapies Awarded $4.8M Grant from The Michael ...

... Grant from The Michael J. Fox Foundation for Parkinson's Research to ... of Parkinson's disease and other neurodegenerative disorders,...

2022-04-17 - MJFF Names German Neurologist as Winner of 2022 ...

Mollenhauer's work has focused on developing biomarkers of early stage, or prodromal, Parkinson's, as well as those tracking disease progression...

2022-03-30 - Nitrase Therapeutics Receives New Grant from The Michael J ...

Fox Foundation for Parkinson's Research (MJFF). This grant was awarded to fund Nitrase's continued research on a novel biomarker identified by...

2021-10-28 - Gain Therapeutics to Present at Upcoming Medical Conferences

- The Michael J. Fox Foundation’s Parkinson’s Disease Therapeutics Webinars - - Society of Neuroscience 50th Anniversary Meeting – BETHESDA, Md., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company focused on identifying ...

2021-04-20 - The Michael J. Fox Foundation for Parkinson's Research Adds Melanie Bolch Isbill, Alex Krys and Jack Quinn to Its Board of Directors

NEW YORK, April 20, 2021 /PRNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) announced that during its Board meeting on March 11, 2021, three new members were appointed to the Board of Directors — Melanie Bolch Isbill, Alex Krys and Jack Quinn. Each provides a diverse a ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$112.6M35921%N/A
#2
$65.1M359N/AN/A
#3
$591.4M3597%N/A
#4
$35M3593%N/A
#5
$121.2M3597%N/A